Volume | 23 060 |
|
|||||
Actualités | - | ||||||
Maximum Haut | Bas Haut |
||||||
Minimum Bas |
Nom Action | Symbole Action | Marché | Type |
---|---|---|---|
Sonoma Pharmaceuticals Inc | SNOA | NASDAQ | Action ordinaire |
Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
---|---|---|---|---|
0,2084 |
Transactions Totales | Volume échangé | Volume en moyenne | Sur 52 semaines |
---|---|---|---|
32 | 23 060 | - | 0,1159 - 1,38 |
Dernière Transaction | Type | Quantités échangées | Prix transaction | Devise |
---|---|---|---|---|
14:55:11 | formt | 120 | US$ 0,2099 | USD |
Bilan Comptable
Capitalisation Boursière | Actions en Circulation | Float | Chiffre d'affaires | Bénéfice/Perte | BPA | Ratio Cours sur Bénéfices |
---|---|---|---|---|---|---|
3,28M | 15,61M | - | 13,27M | -5,15M | -0,33 | - |
Short Interest | Dividendes Par Action | Rendement du Dividende | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
plus d’informations financières »
Actualités Action Sonoma Pharmaceuticals
Date | Heure | Source | Titre |
---|---|---|---|
08/3/2024 | 22:29 | Edgar (US Regulatory) | Form 8-K - Current report |
08/3/2024 | 22:27 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
08/2/2024 | 22:01 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
10/1/2024 | 13:30 | Edgar (US Regulatory) | Form 8-K - Current report |
09/1/2024 | 22:47 | Edgar (US Regulatory) | Form 8-K - Current report |
29/12/2023 | 23:26 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
29/12/2023 | 23:25 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
29/12/2023 | 23:25 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
29/12/2023 | 23:24 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
29/12/2023 | 23:23 | Edgar (US Regulatory) | Form 8-K - Current report |
15/12/2023 | 23:30 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
21/11/2023 | 06:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
Forum Action Sonoma Pharmaceuticals
Aucune Discussion TrouvéeAjouter une Discussion
Historiques Sonoma Pharmaceuticals Inc
Période | Ouver. | Haut | Bas | VWAP | Moyenne Vol. Quot. | Variation | % |
---|---|---|---|---|---|---|---|
1 semaine | 0,189 | 0,2186 | 0,18 | 0,1984255 | 1 427 556 | 0,0209 | 11,06% |
1 mois | 0,1445 | 0,33 | 0,1445 | 0,2395352 | 6 500 803 | 0,0654 | 45,26% |
3 mois | 0,1478 | 0,33 | 0,1311 | 0,2285406 | 2 468 657 | 0,0621 | 42,02% |
6 mois | 0,183 | 0,33 | 0,1301 | 0,20711 | 2 131 305 | 0,0269 | 14,70% |
1 an | 1,30 | 1,38 | 0,1159 | 0,2192067 | 1 289 885 | -1,09 | -83,85% |
3 ans | 7,99 | 13,36 | 0,1159 | 2,85 | 1 095 087 | -7,78 | -97,37% |
5 ans | 0,7899 | 19,54 | 0,1159 | 3,85 | 778 867 | -0,58 | -73,43% |